Find a specific notice:
Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Publication Date
14 Feb 2019

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2019-go667
Title
View PDF
File Type and Size
PDF (29 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Claratyne RediTabs (General sale)
Loratadine 10mg
Orodispersible tablet
Bayer New Zealand Limited
Catalent Pharma Solutions Limited, Swindon, United Kingdom

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Claratyne RediTabs (Pharmacy only)
Loratadine 10mg
Orodispersible tablet
Bayer New Zealand Limited
Catalent Pharma Solutions Limited, Swindon, United Kingdom

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Tecentriq
Atezolizumab 1200mg
Concentrate for infusion
Roche Products (NZ) Limited
Roche Diagnostics GmbH, Mannheim, Germany
F Hoffmann-La Roche Limited, Kaiseraugst, Switzerland

Dated this 11th day of February 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).